- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06296797
Patient-centered Information on Permanent Contraception
Disseminating PCOR Findings to Reduce Racial Disparities in Surgical Sterilization
The goal of this study is to understand whether providing information to women with a strong desire to avoid future pregnancy about how tubal sterilization compares to long-acting reversible contraceptives improves perceived access to available contraceptives.
Participants will:
- Complete a baseline survey
- Receive access to web-based educational resources
- Complete a brief follow up survey immediately after exploring these web-based resources
- Complete a follow-up survey 3 months after enrolling
The investigators will compare outcomes among participants provided with access to a new website (intervention) summarizing recent patient-centered outcomes research (PCOR) comparing interval laparoscopic tubal sterilization and long-acting reversible contraception (LARC) to control participants provided with access to the existing Planned Parenthood website on tubal sterilization.
Study Overview
Status
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Eleanor Schwarz, MD, MS
- Phone Number: 415-502-1826
- Email: eleanor.schwarz@ucsf.edu
Study Contact Backup
- Name: Hannah Begna, MS
- Phone Number: (510) 660-0915
- Email: hannah.begna@ucsf.edu
Study Locations
-
-
California
-
San Francisco, California, United States, 94143
- University of California, San Francisco
-
Contact:
- Eleanor Schwarz, MD, MS
- Email: eleanor.schwarz@ucsf.edu
-
Contact:
- Hannah Begna, MS
- Email: hannah.begna@ucsf.edu
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Self-reported fertility
- Have a strong desire to avoid future pregnancy
- Speak English or Spanish
Exclusion Criteria:
- Current pregnancy
- The inability to speak English or Spanish
- Prior tubal sterilization or Essure procedure
- Menopause
- Infertility
- Hysterectomy
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Comparative information on tubal sterilization and other long-acting contraceptives
A new website comparing tubal sterilization to vasectomy and long-acting reversible contraceptives
|
A website comparing tubal sterilization to long-acting reversible contraceptives informed by recent patient centered outcomes research.
Other Names:
|
Active Comparator: Information on tubal sterilization
Participants will be shown an existing web page developed by Planned Parenthood for people considering tubal sterilization
|
Information about tubal sterilization currently provided on the Planned Parenthood website
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Perceived Access to Long Acting Contraceptives
Time Frame: Immediately after introduction to website and at 3 months follow-up
|
A 9-item, multi-dimensional measure assessing awareness, availability, accessibility, affordability, and acceptability of contraceptive options including tubal sterilization, vasectomy, the subdermal implant, hormonal IUD, and hormone-free IUD.
A summative score ranging from 0 to 48 points will be calculated for each participant at baseline and follow up.
We hypothesize there will be greater improvements from baseline to follow up in the intervention than control arm.
|
Immediately after introduction to website and at 3 months follow-up
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Person-Centered Contraceptive Counseling Measure
Time Frame: 3 month follow-up
|
4-items including: Letting me say what mattered to me about my birth control, Taking my preferences about my birth control seriously, Giving me enough information to make the best decision about my birth control method, Respecting me as a person, with responses range from 1 ("Strongly Disagree") to 5 ("Strongly Agree").
We hypothesize there will be greater improvements from baseline in the intervention than control arm.
|
3 month follow-up
|
Consumer Assessment of Healthcare Providers and Systems
Time Frame: 3 months follow-up
|
Response options on a 10-point Likert scale, ranging from poor (0) to excellent (10). We hypothesize there will be greater improvements from baseline in the intervention than control arm. |
3 months follow-up
|
Patients' Perceived Efficacy in Patient-Physician Interactions (PEPPI)
Time Frame: immediately after introduction to website and 3 months follow-up
|
To create a score on the 5 item contraceptive "PEPPI scale" ranging from 5 (lowest possible score) to 25 (representing highest patient-perceived self-efficacy), each item begins with "How confident are you in your ability to… ", and subjects respond to each question on a scale of 1 to 5, with 5 representing "very confident," and 1 representing "not at all confident" We hypothesize there will be greater improvements from baseline to follow up in the intervention than control arm.
|
immediately after introduction to website and 3 months follow-up
|
Knowledge of Long-Acting Contraceptives
Time Frame: Immediately after introduction to website and at 3 month follow-up
|
10 items adapted from the previously used Tubal Sterilization Knowledge Questionnaire items developed by Hall et al.
Answers will be coded as correct vs. incorrect (with "Don't Know" being coded as an incorrect response) to create a knowledge score.
We will calculate change in knowledge scores on follow up surveys compared to baseline.
We hypothesize there will be greater improvements from baseline in the intervention than control arm.
|
Immediately after introduction to website and at 3 month follow-up
|
Use of preferred method of contraception
Time Frame: 3 month follow-up
|
3 items detailed in prior publication PMID 27710196
|
3 month follow-up
|
Would recommend website to a friend
Time Frame: Immediately after introduction to website, and at 3 month follow up
|
5 items designed to evaluate usability of website and recommendations to friends.
E.g., "Using a scale of 0 (not at all) to 10 (extremely likely), participants will indicate how likely they are to recommend this website to a friend who is considering getting her tubes tied?
(0-10)"
|
Immediately after introduction to website, and at 3 month follow up
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Suggestions for how to improve web-based resources for people considering permanent contraception.
Time Frame: immediately following introduction to website and at 3 months follow-up
|
Open-ended question regarding ease-of-use and helpfulness of the web-based program.
These responses will provide ongoing information to help guide future adaptations and dissemination.
|
immediately following introduction to website and at 3 months follow-up
|
Collaborators and Investigators
Investigators
- Principal Investigator: Eleanor Schwarz, MD, MS, University of California, San Francisco
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 5R18HS029432-02 (U.S. AHRQ Grant/Contract)
- R18HS029432 (U.S. AHRQ Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Contraception
-
Virginia Commonwealth UniversityCompletedPregnancy Related | Contraception | Contraception Behavior | Contraception Use
-
Johnson & Johnson Pharmaceutical Research & Development...CompletedFemale Contraception | Contraception
-
Johnson & Johnson Pharmaceutical Research & Development...Completed
-
Medical University of South CarolinaSociety of Family PlanningCompletedContraception | Contraception BehaviorUnited States
-
Teva Branded Pharmaceutical Products R&D, Inc.CompletedFemale Contraception | ContraceptionUnited States, Israel
-
Johnson & Johnson Pharmaceutical Research & Development...Completed
-
Johnson & Johnson Pharmaceutical Research & Development...CompletedFemale Contraception | Contraception
-
Johnson & Johnson Pharmaceutical Research & Development...CompletedFemale Contraception | Contraception
-
Janssen Pharmaceutica N.V., BelgiumCompleted
-
University of California, Los AngelesCompletedContraception | Mobile Applications | Contraception BehaviorUnited States
Clinical Trials on Advancing Access Website
-
Odense University HospitalCompletedHealth Knowledge, Attitudes, Practice | Downs SyndromeDenmark
-
Berlin School of Public HealthFederal Ministry of Health, GermanyCompletedColorectal CancerGermany
-
University of Texas at AustinNational Heart, Lung, and Blood Institute (NHLBI)RecruitingAsthma in ChildrenUnited States
-
University of New MexicoCompleted
-
University Hospital, RouenNot yet recruitingPaediatric Surgery | Analgesics PrescriptionsFrance
-
University of Wisconsin, MadisonCompletedObesity | Overweight | ChildUnited States
-
University of AlbertaRecruitingCongenital Heart Defect | TransitionCanada
-
University of Wisconsin, MadisonM.D. Anderson Cancer Center; National Cancer Institute (NCI); University of Illinois... and other collaboratorsCompletedLung Cancer, Stage IIIb or IVUnited States
-
Yale UniversityUniversity of Florida; University of Western Ontario, Canada; Harvard University and other collaboratorsCompletedStress, Psychological | Mental Health ImpairmentUnited States
-
Urban InstituteRubicon ProgramsUnknownResponsible Fatherhood ProgrammingUnited States